JMI Hospital Requisite Manufacturing Limited announcements
103 Dhaka Stock Exchange announcements for JMI Hospital Requisite Manufacturing Limited (JHRML) since 2022: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (19).
- Credit Rating Result
Alpha Credit Rating PLC (Alpha Rating) has assigned the Surveillance rating of the Company as "A+" in the long term and "ST-2" in the short term along with Stable outlook based on the audited financial statements as on June 30, 2024 and relevant qualitative information till December 29, 2024.
- Resumption after Record Date
Trading of the shares of the company will resume on 27.11.2024.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 26.11.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 24.11.2024 to 25.11.2024 and trading of the shares will remain suspended on record date i.e., 26.11.2024.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 0.55 for July-September 2024 as against Tk. 0.54 (Solo) for July-September 2023; Consolidated NOCFPS was Tk. 0.14 for July-September 2024 as against Tk. 0.12 (Solo) for July-September 2023. Consolidated NAV per share was Tk. 34.50 as on September 30, 2024 and Tk. 33.95 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- The Board of Directors has recommended 10\% Cash Dividend to general shareholders other than sponsors and directors for
The Board of Directors has recommended 10\% Cash Dividend to general shareholders other than sponsors and directors for the year ended June 30, 2024. Out of the total shares of the company, the sponsors and directors hold 40,464,500 shares and General shareholders hold 84,829,620 shares. The cash dividend payable to the general shareholders is Tk. 84,829,620.00. Date of AGM: 23.01.2025, Time: 11:00 AM, Venue: The AGM venue details will be conveyed through AGM notice. (cont.)
- Dividend Declaration and investment in a Subsidiary
(Cont. news of JHRML): Record Date: 26.11.2024. The Company has also reported consolidated EPS of Tk. 2.34, consolidated NAV per share of Tk. 33.95 and consolidated NOCFPS of Tk. 2.36 for the year ended June 30, 2024 as against Tk. 2.41 (solo), Tk. 32.12 (solo) and Tk. 3.70 (solo) respectively for the year ended June 30, 2023. The Board of Directors has also approved further investment of Tk. 8.00 crore in its subsidiary, JMI Specialized Hospital Limited. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (24.10.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 23, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.56 for January-March 2024 as against Tk. 0.54 for January-March 2023; EPS was Tk. 1.73 for July 2023-March 2024 as against Tk. 1.59 for July 2022-March 2023. NOCFPS was Tk. 1.82 for July 2023-March 2024 as against Tk. 2.16 for July 2022-March 2023. NAV per share was Tk. 33.35 as on March 31, 2024 and Tk. 32.12 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.63 for October-December 2023 as against Tk. 0.52 for October-December 2022; EPS was Tk. 1.17 for July-December 2023 as against Tk. 1.05 for July-December 2022. NOCFPS was Tk. 1.07 for July-December 2023 as against Tk. 0.98 for July-December 2022. NAV per share was Tk. 33.28 as on December 31, 2023 and Tk. 32.12 as on June 30, 2023.
- The company has informed that they formed a subsidiary company on August 06, 2023 in the name of JMI Specialized Hospita
The company has informed that they formed a subsidiary company on August 06, 2023 in the name of JMI Specialized Hospital Limited, a healthcare service providing company, having authorized capital of BDT 50.00 Crore and paid-up capital of BDT 20.00 Crore wherein JHRML holds 65\% shares. JMI Specialized Hospital Limited (JSHL) signed a License Agreement on 23 January 2024 with Apollo Health and Lifestyle Limited (AHLL), Registered office at 7-1-617/A, 615 & 616, Imperial Tower, (cont.)
- (Continuation news of JHRML): 7th floor, Ameerpet Hyderabad, India. Whereas, both the parties have mutually agreed that
(Continuation news of JHRML): 7th floor, Ameerpet Hyderabad, India. Whereas, both the parties have mutually agreed that JSHL will use Apollo Health and Lifestyle Limited\'s trademark, logo and name \"Apollo Clinic\" as well as their technical knowledge, know-how and management expertise for establishing and operating a Clinic in Bangladesh named Apollo Clinic, which has been approved by the Board of Directors of JMI Hospital Requisite Manufacturing Limited in its Meeting held on 23 January 2024. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
- Category Change
The Company will be placed in 'B' category from existing 'A' category with effect from January 23, 2024 as the Company has approved 5% Cash Dividend for the year ended June 30, 2023.
- Shareholders' approval for the revised use of IPO proceeds
Refer to their earlier news disseminated by DSE on 19.10.2023, the company has further informed that the shareholders of the company have approved the revised use of IPO proceeds in the 15th AGM of the company held on January 22, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.